Trial intelligence / Profile preview

SKIP: SPS for Hyperkalemia in Pre-dialysis Outpatients

NCT02065076Phase 4Completed

Sponsor
Hôpital Maisonneuve-Rosemont
Start
Feb 2014
Primary completion
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sodium polystyrene sulfonate in hyperkalemia, sponsored by Hôpital Maisonneuve-Rosemont. Started Feb 2014; status: completed.

02

Drugs

sodium polystyrene sulfonate
03

Conditions

hyperkalemia

Beyond the preview

Go deeper on NCT02065076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02065076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call